Data / Drug companies / Progestin
Progestin drugs: 27 drugs from 90 companies in the FDA NDC directory
Progestin is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 239 products in this class from 90 companies, covering 27 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 17, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 90Companies
- 239Products
- 27Drugs by generic name
Drugs in the Progestin class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Levonorgestrel | 62 | 31 |
| Medroxyprogesterone acetate | 48 | 23 |
| Levonorgestrel and ethinyl estradiol | 3 | 19 |
| Megestrol acetate | 24 | 17 |
| Norethindrone | 20 | 17 |
| Norethindrone and ethinyl estradiol | 1 | 12 |
| Norethindrone acetate and ethinyl estradiol | 19 | 10 |
| Norelgestromin and ethinyl estradiol | 8 | 8 |
| Estradiol and norethindrone acetate | 12 | 7 |
| Etonogestrel and ethinyl estradiol | 8 | 6 |
| Norethindrone acetate | 6 | 6 |
| Estradiol/norethindrone acetate | 6 | 2 |
| Etonogestrel and ethinyl estradiol vaginal | 2 | 2 |
| Conjugated estrogens and medroxyprogesterone acetate | 4 | 1 |
| Drospirenone and estradiol | 2 | 1 |
| Estradiol/norethindrone acetate transdermal system | 2 | 1 |
| Levonorgestrel tablet, 1.5 mg | 2 | 1 |
| Estradiol and levonorgestrel | 1 | 1 |
| Etonogestrel | 1 | 1 |
| Etonogestrel and ethinyl estradiol vaginal ring | 1 | 1 |
| Hydroxyprogesterone caproate | 1 | 1 |
| Junel fe | 1 | 1 |
| Levonorgestrel/ethinyl estradiol | 1 | 1 |
| Medroxyprogesterone | 1 | 1 |
| Norelgestromin and ethinly estradiol | 1 | 1 |
| Relugolix, estradiol hemihydrate, and norethindrone acetate | 1 | 1 |
| Segesterone acetate and ethinyl estradiol | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 14 | tablet; insert, extended release | Generic drugs (ANDA) | May 19, 2025 |
| Xiromed, LLC | 10 | tablet; injection, suspension | Generic drugs (ANDA) | January 29, 2025 |
| Teva Pharmaceuticals USA, Inc. | 9 | tablet | Generic drugs (ANDA) | September 18, 2003 |
| Glenmark Pharmaceuticals Inc., USA | 8 | tablet | Generic drugs (ANDA) | June 5, 2018 |
| Bayer HealthCare Pharmaceuticals Inc. | 6 | intrauterine device; tablet, film coated | New drug applications (NDA) | September 19, 2016 |
| Julie Products Inc. | 6 | tablet | Generic drugs (ANDA) | September 17, 2026 |
| Pharmacia & Upjohn Company LLC | 6 | tablet; injection, suspension | New drug applications (NDA) | July 20, 2020 |
| Rapha Pharmaceuticals, Inc. | 6 | tablet | Generic drugs (ANDA) | November 21, 2023 |
| Amneal Pharmaceuticals NY LLC | 5 | tablet, film coated; patch | New drug applications (NDA) | February 26, 2021 |
| Aurohealth LLC | 5 | tablet | Generic drugs (ANDA) | March 23, 2023 |
| Foundation Consumer Healthcare | 5 | tablet | Authorized generics (NDA) | June 15, 2019 |
| Ingenus Pharmaceuticals, LLC | 5 | tablet | Generic drugs (ANDA) | November 30, 2022 |
| Lupin Pharmaceuticals, Inc. | 5 | tablet; tablet, film coated | Generic drugs (ANDA) | November 11, 2020 |
| Remedyrepack Inc. | 5 | tablet; injection, suspension | Generic drugs (ANDA) | October 17, 2026 |
| Sun Pharmaceutical Industries, Inc. | 5 | tablet; injection, suspension | Generic drugs (ANDA) | May 4, 2019 |
| Bryant Ranch Prepack | 4 | tablet | Generic drugs (ANDA) | December 4, 1996 |
| Mylan Pharmaceuticals Inc. | 4 | tablet; patch | Generic drugs (ANDA) | September 25, 2019 |
| Ohm Laboratories Inc. | 4 | tablet | Generic drugs (ANDA) | September 1, 2026 |
| Proficient Rx LP | 4 | tablet; suspension | Generic drugs (ANDA) | April 18, 2018 |
| Wyeth Pharmaceuticals LLC, a Subsidiary of Pfizer Inc. | 4 | tablet, sugar coated | New drug applications (NDA) | December 3, 2012 |
| American Health Packaging | 3 | tablet; suspension | Generic drugs (ANDA) | January 14, 2026 |
| Amneal Pharmaceuticals LLC | 3 | ring; patch | Generic drugs (ANDA) | June 28, 2020 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | June 26, 2017 |
| Aurobindo Pharma Limited | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | June 30, 2023 |
| AvKARE | 3 | ring; patch | Generic drugs (ANDA) | September 21, 2023 |
| Eugia US LLC | 3 | injection, suspension; injection | Generic drugs (ANDA) | August 31, 2022 |
| Mylan Pharmaceuticals Inc. | 3 | tablet | Authorized generics (NDA) | August 20, 2018 |
| Naari Pte Limited | 3 | tablet | Generic drugs (ANDA) | June 11, 2024 |
| Prasco Laboratories | 3 | injection, suspension; insert, extended release | Authorized generics (NDA) | October 21, 2021 |
| Preferred Pharmaceuticals Inc. | 3 | tablet; suspension | Generic drugs (ANDA) | July 12, 2024 |
| Strides Pharma Science Limited | 3 | tablet; suspension | Generic drugs (ANDA) | April 11, 2022 |
| Teva Pharmaceuticals USA, Inc. | 3 | tablet; tablet, film coated | Generic drugs (ANDA) | January 19, 2021 |
| Afaxys Pharma, LLC | 2 | tablet | Generic drugs (ANDA) | February 8, 2018 |
| Amneal Pharmaceuticals LLC | 2 | injection, suspension | Generic drugs (ANDA) | June 13, 2023 |
| Amneal Pharmaceuticals LLC | 2 | tablet, film coated | New drug applications (NDA) | May 1, 2019 |
| Amphastar Pharmaceuticals, Inc. | 2 | injection, suspension, extended release | Generic drugs (ANDA) | November 28, 2017 |
| Breckenridge Pharmaceutical, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | June 9, 2011 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | April 4, 2022 |
| Cadence Health, Inc. | 2 | tablet | Generic drugs (ANDA) | April 15, 2025 |
| Cardinal Health 110, LLC. DBA Leader | 2 | tablet | Generic drugs (ANDA) | July 15, 2024 |
| Dr. Reddy's Laboratories Inc. | 2 | tablet | Generic drugs (ANDA) | May 6, 2024 |
| Glenmark Therapeutics Inc., USA | 2 | tablet | Generic drugs (ANDA) | February 9, 2023 |
| Golden State Medical Supply, Inc. | 2 | tablet; suspension | Generic drugs (ANDA) | July 25, 2001 |
| L. Perrigo Company | 2 | tablet | Generic drugs (ANDA) | April 20, 2026 |
| Major Pharmaceuticals | 2 | tablet; suspension | Generic drugs (ANDA) | December 29, 2025 |
| NorthStar Rx LLC | 2 | ring; tablet | Generic drugs (ANDA) | November 1, 2023 |
| Noven Therapeutics, LLC | 2 | patch, extended release | New drug applications (NDA) | August 7, 1998 |
| NuCare Pharmaceuticals,Inc. | 2 | tablet | Generic drugs (ANDA) | April 25, 2017 |
| Organon LLC | 2 | implant; insert, extended release | New drug applications (NDA) | June 1, 2021 |
| Pai Holdings, LLC DBA Pai Pharma | 2 | suspension | Generic drugs (ANDA) | October 17, 2025 |
| Precision Dose, Inc. | 2 | suspension | Generic drugs (ANDA) | July 11, 2022 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | November 3, 2010 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | November 11, 2020 |
| Strides Pharma Inc | 2 | tablet | Generic drugs (ANDA) | September 15, 2022 |
| Teva Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | December 1, 2023 |
| Teva Women's Health LLC | 2 | tablet | Generic drugs (ANDA) | February 26, 2015 |
| Yyba Corp | 2 | tablet | Generic drugs (ANDA) | September 1, 2026 |
| Advanz Pharma (US) Corp. | 1 | insert, extended release | New drug applications (NDA) | May 19, 2025 |
| Agile Therapeutics, Inc. | 1 | patch | New drug applications (NDA) | September 11, 2020 |
| Allergan, Inc. | 1 | intrauterine device | New drug applications (NDA) | May 31, 2016 |
| Amazon.com Services LLC | 1 | tablet | Generic drugs (ANDA) | May 15, 2024 |
| Amneal Pharmaceuticals NY LLC | 1 | injection, suspension | Generic drugs (ANDA) | June 10, 2025 |
| Ani Pharmaceuticals, Inc. | 1 | suspension | Generic drugs (ANDA) | July 2, 2024 |
| Atlantic Biologicals Corp. | 1 | suspension | Generic drugs (ANDA) | March 21, 2022 |
| Bryant Ranch Prepack | 1 | patch | Generic drugs (ANDA) | June 28, 2020 |
| Camber Consumer Care Inc | 1 | tablet | Generic drugs (ANDA) | September 30, 2025 |
| Coupler LLC | 1 | tablet | Generic drugs (ANDA) | January 30, 2025 |
| Direct_Rx | 1 | tablet | Generic drugs (ANDA) | October 6, 2021 |
| Get Stix Inc. | 1 | tablet | Generic drugs (ANDA) | December 19, 2025 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection, suspension | Generic drugs (ANDA) | May 1, 2023 |
| Home Health Brands, LLC | 1 | tablet | Generic drugs (ANDA) | April 28, 2025 |
| Kesin Pharma Corporation | 1 | suspension | Generic drugs (ANDA) | August 7, 2025 |
| Lupin Pharmaceuticals,Inc. | 1 | tablet | Generic drugs (ANDA) | February 15, 2013 |
| Mayne Pharma | 1 | ring | New drug applications (NDA) | August 16, 2024 |
| Mylan Institutional LLC | 1 | injection, suspension | Generic drugs (ANDA) | October 12, 2018 |
| Natco Pharma USA LLC | 1 | suspension | Generic drugs (ANDA) | July 31, 2023 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | December 27, 2023 |
| Novel Laboratories, Inc. | 1 | tablet | Generic drugs (ANDA) | February 15, 2013 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | December 4, 1996 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | December 4, 1996 |
| PharmPak, Inc. | 1 | tablet | Generic drugs (ANDA) | July 12, 2019 |
| Rugby Laboratories | 1 | tablet | Generic drugs (ANDA) | May 24, 2024 |
| Sumitomo Pharma America, Inc. | 1 | tablet, film coated | New drug applications (NDA) | May 26, 2021 |
| Syzygy Healthcare Solutions, LLC Po Box 588, Westport, CT 06880 | 1 | tablet | Generic drugs (ANDA) | September 14, 2017 |
| Thirty Madison Inc | 1 | tablet | Generic drugs (ANDA) | January 2, 2025 |
| Upsher-Smith Laboratories, LLC | 1 | suspension | Generic drugs (ANDA) | March 1, 2015 |
| Viatris Specialty LLC | 1 | patch | New drug applications (NDA) | October 1, 2026 |
| Xttrium Laboratories, Inc. | 1 | suspension | Generic drugs (ANDA) | March 28, 2025 |
| Zydus Lifesciences Limited | 1 | patch | Generic drugs (ANDA) | November 21, 2023 |
| Zydus Pharmaceuticals USA Inc. | 1 | patch | Generic drugs (ANDA) | November 21, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 151 | 63.2% |
| Injection, suspension | 18 | 7.5% |
| Tablet, film coated | 17 | 7.1% |
| Suspension | 16 | 6.7% |
| Patch | 11 | 4.6% |
| Insert, extended release | 7 | 2.9% |
| Ring | 5 | 2.1% |
| Intrauterine device | 4 | 1.7% |
| Tablet, sugar coated | 4 | 1.7% |
| Patch, extended release | 2 | 0.8% |
| Injection, suspension, extended release | 2 | 0.8% |
| Implant | 1 | 0.4% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.